Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chao Quan

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 27, 2024
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBaseTim Spelman, Sara Eichau, Raed Alroughani, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Nature Communications|August 12, 2025
A citrullinated histone H3 monoclonal antibody for immune modulation in sepsisWenlu Ouyang, Yuchen Chen, Tao Tan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Nature Structural & Molecular Biology|January 20, 2026
Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicryStefano Annunziato, Chao Quan, Etienne J Donckele, et al.
Science (New York, N.Y.)|July 3, 2025
Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognitionGeorg Petzold, Pablo Gainza, Stefano Annunziato, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 27, 2024
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBaseTim Spelman, Sara Eichau, Raed Alroughani, et al.
Mabs|August 13, 2025
Building a potent TREM2 agonistic, biparatopic, common light chain antibodyAna da Silva Almeida, Melissa L Geddie, Anil Bhate, et al.
Nature Communications|August 12, 2025
A citrullinated histone H3 monoclonal antibody for immune modulation in sepsisWenlu Ouyang, Yuchen Chen, Tao Tan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 31, 2023
International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.
Nature Structural & Molecular Biology|January 20, 2026
Cereblon induces G3BP2 neosubstrate degradation using molecular surface mimicryStefano Annunziato, Chao Quan, Etienne J Donckele, et al.
Science (New York, N.Y.)|July 3, 2025
Mining the CRBN target space redefines rules for molecular glue-induced neosubstrate recognitionGeorg Petzold, Pablo Gainza, Stefano Annunziato, et al.
Pageof 21